Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Buhl

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2020
Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric StudyPhilipp Solbach, Patrick Chhatwal, Sabrina Woltemate, et al.
The Lancet. Infectious Diseases|January 22, 2022
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort studyEvelina Tacconelli, Siri Göpel, Beryl P Gladstone, et al.
Journal of Microbiological Methods|September 9, 2022
Machine learning-based typing of Salmonella enterica O-serogroups by the Fourier-Transform Infrared (FTIR) Spectroscopy-based IR Biotyper systemMiriam Cordovana, Norman Mauder, Olivier Join-Lambert, et al.
Nature Communications|January 10, 2023
Resolving colistin resistance and heteroresistance in Enterobacter speciesSwapnil Prakash Doijad, Nicolas Gisch, Renate Frantz, et al.
The Journal of Hospital Infection|February 22, 2026
All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multicentre cohort study in six German university hospitals, 2016-2020Anna M Rohde, Winfried V Kern, Michael Behnke, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infection|December 26, 2022
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective studyAlaa Atamna, Ili Margalit, Gida Ayada, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2020
Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric StudyPhilipp Solbach, Patrick Chhatwal, Sabrina Woltemate, et al.
The Lancet. Infectious Diseases|January 22, 2022
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort studyEvelina Tacconelli, Siri Göpel, Beryl P Gladstone, et al.
Journal of Microbiological Methods|September 9, 2022
Machine learning-based typing of Salmonella enterica O-serogroups by the Fourier-Transform Infrared (FTIR) Spectroscopy-based IR Biotyper systemMiriam Cordovana, Norman Mauder, Olivier Join-Lambert, et al.
Nature Communications|January 10, 2023
Resolving colistin resistance and heteroresistance in Enterobacter speciesSwapnil Prakash Doijad, Nicolas Gisch, Renate Frantz, et al.
The Journal of Hospital Infection|February 22, 2026
All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multicentre cohort study in six German university hospitals, 2016-2020Anna M Rohde, Winfried V Kern, Michael Behnke, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infection|December 26, 2022
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective studyAlaa Atamna, Ili Margalit, Gida Ayada, et al.
Pageof 3